A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.

Completed

Conditions studied: Gonorrhea, Chlamydia, Meningococcal Vaccines

In brief

Brief Summary: The main purpose of the study is to learn about how well Trumenba vaccine shot works against gonorrhea infection. This study looks at data records from a database in the United States. This study includes patient's data from the database who: * Are 15-30 years old. * Have received at least one dose of Trumenba and a MenACWY vaccine or who have received only MenACWY vaccine. This data has already been collected in the past and is being studied between April and June of 2023.

Key facts

Study ID

NCT05873751

Run by

Pfizer

People needed

1307378

Starts

2023-04-24

Expected to finish

2024-03-31

Last updated by the study team

2025-04-17

Who can join

Age: 15 and older, up to 30. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals of 15-30 years old registered in the PharMetrics Plus system
• Individuals having the index vaccination event at the age of 15-30 in 2016-2021

You may not qualify if…

• Individuals having any dose of Bexsero at any time during the study period and prior to the study
• Individuals with incomplete information on variables to be collected.

Where it is running

• Pfizer — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.